Molecular Testing Considerations for Patients With Pancreatic Cancer

Download this slideset to review the latest data on molecular testing considerations for patients with pancreatic cancer.
Michael J. Pishvaian, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.59 MB
Released: September 21, 2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

From Clinical Care Options (CCO), download a PDF featuring expert discussion on using immunotherapy for patients with advanced HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 22, 2021

From Clinical Care Options (CCO), download a PDF featuring expert answers to clinician questions on using immunotherapy for patients with advanced HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 21, 2021

Downloadable slideset reviewing the latest therapeutic approaches for pancreatic cancer harboring BRCA mutations, from Clinical Care Options (CCO)

person default Dirk Arnold, MD, PhD Released: January 21, 2021

Downloadable slideset reviewing global perspectives on biomarker-driven therapeutic strategies for pancreatic cancer, from Clinical Care Options (CCO)

Philip Agop Philip, MD, PhD, FRCP Released: January 20, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue